Loading...
XJPX7459
Market cap3.16bUSD
Dec 25, Last price  
2,361.50JPY
1D
-0.04%
1Q
-5.90%
Jan 2017
29.41%
Name

Medipal Holdings Corp

Chart & Performance

D1W1MN
XJPX:7459 chart
P/E
11.84
P/S
0.14
EPS
199.44
Div Yield, %
2.28%
Shrs. gr., 5y
-2.20%
Rev. gr., 5y
2.26%
Revenues
3.56t
+5.91%
1,665,902,000,0001,921,714,000,0002,166,846,000,0002,255,046,000,0002,463,807,000,0002,545,985,000,0002,662,887,000,0002,750,215,000,0002,810,914,000,0002,947,738,000,0002,872,913,000,0003,028,235,000,0003,064,041,000,0003,146,341,000,0003,181,935,000,0003,253,122,000,0003,211,173,000,0003,290,921,000,0003,360,008,000,0003,558,732,000,000
Net income
41.47b
+6.88%
8,729,000,00020,842,000,00019,105,000,00027,794,000,00012,510,000,0001,958,000,0001,704,000,00011,650,000,00018,655,000,00025,485,000,00023,687,000,00030,771,000,00029,011,000,00034,780,000,00034,359,000,00037,968,000,00023,926,000,00029,423,000,00038,806,000,00041,474,000,000
CFO
61.84b
+283.02%
26,301,000,00041,795,000,00019,836,000,00023,964,000,00023,370,000,00013,992,000,00049,474,000,000-1,988,000,00061,769,000,000-72,000,00080,466,000,00021,985,000,00047,954,000,00063,558,000,00063,716,000,00056,917,000,00034,448,000,00061,216,000,00016,146,000,00061,843,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 03, 2025

Profile

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
URL
https://www.medipal.co.jp/
IPO date
Sep 14, 1995
Employees
12,795
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
3,558,732,000
5.91%
3,360,008,000
2.10%
3,290,921,000
2.48%
Cost of revenue
3,497,754,000
3,154,611,000
3,092,201,000
Unusual Expense (Income)
NOPBT
60,978,000
205,397,000
198,720,000
NOPBT Margin
1.71%
6.11%
6.04%
Operating Taxes
22,973,000
21,738,000
18,087,000
Tax Rate
37.67%
10.58%
9.10%
NOPAT
38,005,000
183,659,000
180,633,000
Net income
41,474,000
6.88%
38,806,000
31.89%
29,423,000
22.98%
Dividends
(11,179,000)
(9,658,000)
(8,818,000)
Dividend yield
2.28%
2.47%
1.96%
Proceeds from repurchase of equity
(10,090,000)
26,098,000
(3,822,000)
BB yield
2.05%
-6.69%
0.85%
Debt
Debt current
6,672,000
30,078,000
Long-term debt
683,000
712,000
6,398,000
Deferred revenue
Other long-term liabilities
19,915,000
19,996,000
25,034,000
Net debt
(449,303,000)
(404,489,000)
(444,847,000)
Cash flow
Cash from operating activities
61,843,000
16,146,000
61,216,000
CAPEX
(19,395,000)
(13,504,000)
(18,877,000)
Cash from investing activities
(7,817,000)
(39,494,000)
(24,343,000)
Cash from financing activities
(25,248,000)
(43,541,000)
(16,471,000)
FCF
15,784,000
179,670,000
177,847,000
Balance
Cash
230,470,000
195,031,000
261,920,000
Long term investments
219,516,000
216,842,000
219,403,000
Excess cash
272,049,400
243,872,600
316,776,950
Stockholders' equity
658,059,000
612,745,000
573,775,000
Invested Capital
484,477,600
458,697,400
373,363,050
ROIC
8.06%
44.15%
48.22%
ROCE
7.71%
28.26%
27.73%
EV
Common stock shares outstanding
211,784
216,346
223,123
Price
2,320.00
28.60%
1,804.00
-10.47%
2,015.00
-5.13%
Market cap
491,338,880
25.89%
390,288,184
-13.19%
449,592,845
-5.11%
EV
178,298,880
112,496,184
123,529,845
EBITDA
78,960,000
220,045,000
213,058,000
EV/EBITDA
2.26
0.51
0.58
Interest
8,000
34,000
16,000
Interest/NOPBT
0.01%
0.02%
0.01%